{"name":"Realm Therapeutics, Inc.","slug":"realm-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPS2NjdlNreDBiUlFVd1dQNHZUbldHVDBWZUJRUTd2d2ZNRFBYcUV3ZzBzZ1laTWJIMFdtc0xZVm0yUndxVVQyZHBLekpUaEVuRFBvQ1RVSWtQNk8xY0M4U2VmZHhfNVVhdzZQdEZNanlmdkJxWTFoc01fWHZ0Wm9SOXB4V0M5ZTNQQXpzeEh6SFdwc1cxdEg5cVJVNA?oc=5","date":"2026-02-12","type":"pipeline","source":"Pharma Voice","summary":"Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift - Pharma Voice","headline":"Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcUZlOEU3XzNsY1Ixem8zbkpRcEJFaXhPVGctRU5pd1ZVd0FRS3VsU0E0NXpzMHhUaFJiOHdZWnowVHJxVEg2OGxsaUVpaHRTNENtdkVfRW50QmpTb1puWDhCWHM1ZmZ4ODF4ZlNBZE04dmdNb3hQbjU5Wk9sQmZpZ2hzeE9XNmZGY0VjeTk4YUhSSGxlLWN4SWU4N1A2ckZRWTN1WlV6UlgyUQ?oc=5","date":"2026-02-09","type":"deal","source":"BioSpace","summary":"Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune - BioSpace","headline":"Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOb3dIVXJhSjUzUXBMbkxKMEdBWmk4cEotQTBtendXbFg1aU9JNUJKYTc2SGxEbGVlRlowcm5lcnByYzNwZGtrbUVuclA5VUJiVWxpTmQ1TUVtNDdpUWFFWUF0VTRUY01aQjVOMzdSdm9tLV84MEVWQ1NRbWV0WHd0cGFQMzMzakMxMWVkTUFKNA?oc=5","date":"2026-01-06","type":"regulatory","source":"OncLive","summary":"Q1 2026: 5 FDA Decisions to Watch in the Realm of Oncology - OncLive","headline":"Q1 2026: 5 FDA Decisions to Watch in the Realm of Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxONDNjckZvbjU5akprZTh5WmxDbEZGT0kzWUt6NFNnSDdkckNDX2FFLUprOExrNUNsUTJSaXJZSWNydXVPR2JjOU1NajBkeE80bWo0a1BxQTBUcU91R3NGbk0yYjFPQ0xNNW1oejdHWFJjdEhiYVQ4QkpVeW91V1Z6VGFVU1FVYm9LRUE?oc=5","date":"2025-12-17","type":"pipeline","source":"StocksToTrade","summary":"Recursion Pharmaceuticals: Is Now the Time to Invest? - StocksToTrade","headline":"Recursion Pharmaceuticals: Is Now the Time to Invest?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNVGJleEJjZ0JuLTNJR1dLQW1vajNrUl9JLVUyTGt1S3hyaV8xUDJCNldRVndXUExTZ2FkeGdMU0JoalVYRnNSZWJNVlp3TGVOYm5lMDVoYmdCTTBUYkdvWXJaMTE1cDF2enNXWXpDRzA1YlFkSkdKYVJWQW1aVjhmR0l5NWlYRHhpQl8wdFk2bmVEZV84d2FhWlZ3RTJKMlRTRGRCSzhB?oc=5","date":"2025-10-16","type":"pipeline","source":"Fierce Pharma","summary":"Veradermics, looking to tousle the pattern hair loss market, locks down $150M series C - Fierce Pharma","headline":"Veradermics, looking to tousle the pattern hair loss market, locks down $150M series C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQUkNTd2pKVVNhV0phNkstVkNoRE9GRk9MRmVDUy1VT1lWNkhqajE2MXpuRXBFU2tZTVlzeUxZTDk1bFRDVV9xLS1qb1lOdHozRVI0aDZ1NXFfdkJYWVNzdVF3WnJNSXU3S2FrRTlPeC1abHBsR1d3X2g0RTlKTDBucGJXRXhLUklBQmV1Ynlsb2VNWThZaE03bWZidXZPTEdicnBOa3NxOEo?oc=5","date":"2023-10-13","type":"trial","source":"The Business Journals","summary":"Schizophrenia drug developer eyes late-stage clinical trial data this month - The Business Journals","headline":"Schizophrenia drug developer eyes late-stage clinical trial data this month","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZF8yWXhvbmh0M3NFaEJKYVVPMGZTLWE3RXFVdzgzX25zMjJUbktnWE1CcHN0WXpNRFE4SGFzLWNTUFBybTZFaDlzX2hpTnd6MnFldkhQZldQd3ByWTZ2dVZhcXZjUk15VnNwQUI5NGFCMnN4UE5zcl93QXNibmplOU5OR0pIdGh6VlJMT3h2dGVUV203VjY0YVA2eEZGVlBJbE8xYXUtOFA1YThhWW0wLV83SGc4YXdURGc?oc=5","date":"2023-09-07","type":"pipeline","source":"UConn Today","summary":"Raman Bahal Receives the Oligonucleotide Therapeutic Society Young Investigator Award - UConn Today","headline":"Raman Bahal Receives the Oligonucleotide Therapeutic Society Young Investigator Award","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNam1QRUZCTTdxbUM4ZlNHRUxzVENqdUR3YXl1aEpDN3ZkdVhHUmprZFJIb2ptZnRqaGRrOXMyeXBIYngyMzJsbnc3Z2ZTbTRYWGZCd2pGenlEcUVxOGwzLTFzemFrd2cwVjZockJwZlJLNUdUdjBPdkZxWG5IOW4wWUlDcFBCTXNVR2VwNm4ySXZ5S3YzYUJxU0cyZnMzbEZiVlR2UG5rYk5BTW5PUDNFLXBn?oc=5","date":"2022-04-26","type":"trial","source":"MedCity News","summary":"Biofourmis adds $300M to ramp up in virtual care, digital therapy clinical trials - MedCity News","headline":"Biofourmis adds $300M to ramp up in virtual care, digital therapy clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNdklHT2ZFTFl0UFZmYjRMVjRORW1SYUFEUjYydUxYNlpSNC05NWVmOWkzdXBpWjlKVi13VWJhaHR0NFVTTUZjMTA2WVhIcUpBUXJxZ0RvS2RfeUV2RGo5aUFveGZYVkFBTFlpd3llaVNGdVpyVTRVZHgzTGVPN1ZyeTRhTFNnTTg4ODJNZWJqOC11Zw?oc=5","date":"2019-08-24","type":"pipeline","source":"Yahoo Finance","summary":"10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance","headline":"10 Biopharmaceutical Companies Trying To Cure Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNN2d5NWttekNGaHdHUFNqOFMyV3hKZFlob0Y1Z1ZTRUhNNjVqOV83TkYxbHZXczNkN1g4QmZENHNTeHJBM1dzNWl2UlJObktZenc3WkdmWF9iRURMTUtKWXpYUmRNSUpMWEFuNXVFQU1RY0VIUWx6NnF0MndRQmhGcEs3UF9JVU0xQ3JfSzJ0M29peFJ6ajJCenVTTV9PRTFRX2c?oc=5","date":"2019-05-16","type":"deal","source":"Fierce Biotech","summary":"Essa strikes deal to buy Realm, gaining cash to fund cancer R&D - Fierce Biotech","headline":"Essa strikes deal to buy Realm, gaining cash to fund cancer R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNNTZLQkZfUFhNQlZJeDhIX211aEVwVVNIaXQ1OTVNZlBNNEZXb2t6ckEwdmRCSkxHWjlONTd1VkQ2WUZwck1CVUVjS3NFRVhMRTBJV1RiMDlKNmlMUjNyblAyM0ZCc0dOLXpYMktiaXlaMmFFcTQ2dzNtTFdzYlB0TDRuVGFCNzUtQy1teWtkNFdmdF9QY2hGUkNmbjQzYVJDV25vWGNEb0JmU04xazNVYTF4cWpKVE9LMzhucmZYSWpkRTAwVlVsYTY0eHNXdFpjakx2MTRrRlVGUUtrZWxRdjVaUQ?oc=5","date":"2019-04-09","type":"pipeline","source":"prnewswire.com","summary":"URGO Medical Strengthens Its Position in North America by Acquiring Realm Therapeutics' Assets - prnewswire.com","headline":"URGO Medical Strengthens Its Position in North America by Acquiring Realm Therapeutics' Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZHMtVUdXdGVvM2g3RWo5WXdNNlZOcktmcnZkOERydVpEcEZIOEgtYUx5cmZySU8zaWlFWmk5S2F4VVhIcGZMeVZ2QXc5QW85OTFzN3MxZkdXb3RvaC15MmU4Ni01bThNZTVWeklvOHJYaEc4UWlVSEpmLWhxNUZOWFAtdGx3T0JQdUF3?oc=5","date":"2019-01-15","type":"patent","source":"Optometry Times","summary":"A look at the latest and upcoming pharmaceutical patents - Optometry Times","headline":"A look at the latest and upcoming pharmaceutical patents","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}